Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 952 of 1,261

  1. US 8013008

    Cyclic amine compound

    Takeda Pharmaceutical Company Limited · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  2. US 8013006

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  3. US 8013005

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  4. US 8012999

    Modulators of CFTR

    Vertex Pharmaceuticals Incorporated · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  5. US 8012699

    Recombinant antigens for diagnosis and prevention of murine typhus

    United States of America as represented by the Secretary of the Air Force · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  6. US 8012946

    Anti-angiogenic methods and compositions

    Sangamo Biosciences, Inc. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  7. US 8012976

    Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

    BIOMARIN PHARMACEUTICAL INC. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  8. US 8012955

    N-substituted-heterocycloalkyloxybenzamide compounds and methods of use

    Rigel Pharmaceuticals, Inc. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  9. US 8012476

    Molecules with extended half-lives, compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  10. US 8012730

    Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  11. US 8012493

    Malaria vaccines

    The United States of America as represented by the Secretary of the Army · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  12. US 8013152

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  13. US 8012490

    Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  14. US 8012739

    Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA synthetase pairs

    The Regents of the University of California · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  15. US 8012965

    Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  16. US 8008323

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  17. US 8008266

    Methods of treating cancer using immunostimulatory oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  18. US 8008510

    Metalloprotein inhibitors

    The Regents of the University of California · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  19. US 8008525

    Receptor function regulating agent

    Takeda Pharmaceutical Company Limited · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  20. US 8007853

    Vitamin/mineral composition with DHA

    Xanodyne Pharmaceuticals, Inc. · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  21. US 8008278

    Diarylmethyl and related compounds

    Theravance, Inc. · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  22. US 8008038

    Methods for determining oxygen concentration with protoporphyrin IX

    ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  23. US 8008308

    Phosphonate compounds

    The Regents of the University of California · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  24. US 8007804

    Complement receptor 2 targeted complement modulators

    The Regents of the University of Colorado · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.